Literature DB >> 7558531

Immune function in athletes versus nonathletes.

D C Nieman1, D Brendle, D A Henson, J Suttles, V D Cook, B J Warren, D E Butterworth, O R Fagoaga, S L Nehlsen-Cannarella.   

Abstract

The purpose of this study was to compare natural killer cell cytotoxic activity (NKCA) and Con A-induced lymphocyte proliferation (T cell function) in athletes versus nonathletes, with measurement of natural killer (NK) and T cells to allow a comparison on a "per-cell" adjusted basis. Eighteen young male endurance athletes (10 runners and 8 cyclists) with a mean VO2max of 70.7 +/- 1.3 ml.kg-1.min-1 and 6.6 +/- 0.8 years of competitive experience were compared with 11 nonathletic male adults (47.6 +/- 3.1 ml.kg-1.min-1). Concentrations of circulating leukocyte and lymphocyte subsets, including NK and T cells, were not significantly different between groups. NKCA and T cell function also did not differ between groups, whether expressed unadjusted or adjusted on a per-cell basis. For all subjects combined, both NKCA and T cell function were unrelated to VO2max (r = 0.005, p = 0.98; r = 0.007, p = 0.97, respectively). These data do not support the contention that immune function, as measured in this study, is altered in endurance athletes.

Mesh:

Year:  1995        PMID: 7558531     DOI: 10.1055/s-2007-973014

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  10 in total

1.  Immune function in female elite rowers and non-athletes.

Authors:  D C Nieman; S L Nehlsen-Cannarella; O R Fagoaga; D A Henson; M Shannon; J M Hjertman; R L Schmitt; M R Bolton; M D Austin; B K Schilling; R Thorpe
Journal:  Br J Sports Med       Date:  2000-06       Impact factor: 13.800

2.  Effects of exercise and training on natural killer cell counts and cytolytic activity: a meta-analysis.

Authors:  R J Shephard; P N Shek
Journal:  Sports Med       Date:  1999-09       Impact factor: 11.136

Review 3.  Lymphocyte responses to maximal exercise: a physiological perspective.

Authors:  Henning Bay Nielsen
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

4.  Effects of endurance training on intracellular calcium concentration in T lymphocytes.

Authors:  Suzanne Broadbent; Gregory Gass
Journal:  Eur J Appl Physiol       Date:  2006-08-12       Impact factor: 3.078

5.  Risk of upper respiratory tract infection in athletes: an epidemiologic and immunologic perspective.

Authors:  D C Nieman
Journal:  J Athl Train       Date:  1997-10       Impact factor: 2.860

6.  The effects of incremental submaximal exercise on circulating leukocytes in physically active and sedentary males and females.

Authors:  N M Moyna; G R Acker; K M Weber; J R Fulton; F L Goss; R J Robertson; B S Rabin
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 7.  Effect of dietary intake on immune function in athletes.

Authors:  Jaya T Venkatraman; David R Pendergast
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

8.  Effects of moderate endurance exercise and training on in vitro lymphocyte proliferation, interleukin-2 (IL-2) production, and IL-2 receptor expression.

Authors:  S G Rhind; P N Shek; S Shinkai; R J Shephard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

9.  Effect of Acute and Chronic Aerobic Exercise on Immunological Markers: A Systematic Review.

Authors:  Ciro Alexandre Mercês Gonçalves; Paulo Moreira Silva Dantas; Isis Kelly Dos Santos; Matheus Dantas; Daliana Caldas Pessoa da Silva; Breno Guilherme de Araújo Tinoco Cabral; Ricardo Oliveira Guerra; Geraldo Barroso Cavalcanti Júnior
Journal:  Front Physiol       Date:  2020-01-24       Impact factor: 4.566

10.  Extracellular flux analyses reveal differences in mitochondrial PBMC metabolism between high-fit and low-fit females.

Authors:  Joëlle J E Janssen; Bart Lagerwaard; Mojtaba Porbahaie; Arie G Nieuwenhuizen; Huub F J Savelkoul; R J Joost van Neerven; Jaap Keijer; Vincent C J de Boer
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-01-10       Impact factor: 4.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.